Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Glenzocimab

Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.

Product Specifications

CAS Number

2101829-58-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Human Neuropeptide B (NPB)
RPC27534-01 20 µg

Recombinant Human Neuropeptide B (NPB)

Sign In for Pricing
View Details
Recombinant Human Neuropeptide B (NPB)
RPC27534-02 100 µg

Recombinant Human Neuropeptide B (NPB)

Sign In for Pricing
View Details
Recombinant Human Neuropeptide B (NPB)
RPC27534-03 1 mg

Recombinant Human Neuropeptide B (NPB)

Sign In for Pricing
View Details
Fmoc-D-Gln(Trt)-OH
TRC-F680028-100MG 100 mg

Fmoc-D-Gln(Trt)-OH

Sign In for Pricing
View Details
FAM43A Protein Vector (Human) (pPM-C-HA)
20027021 500 ng

FAM43A Protein Vector (Human) (pPM-C-HA)

Sign In for Pricing
View Details
HNRNPA1P14 AAV Vector (Human) (CMV)
23707101 1 µg

HNRNPA1P14 AAV Vector (Human) (CMV)

Sign In for Pricing
View Details